Form 10-Q COLLEGIUM PHARMACEUTICAL For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Collegium Pharmaceutical (COLL) PT Lowered to $26 at Needham & Company
November 5, 2021 7:43 AM EDTNeedham & Company analyst Serge Belanger lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $26.00 (from $32.00) while maintaining a Buy rating.
The analyst commented, "Xtampza struggled in 3Q21 with sales of $30.0MM (-9%Q/Q and -7%Y/Y) due to... More
